Athersys Hosting KOL Panel Event to Discuss TREASURE Data

Webinar scheduled for June 14, 2022 at 5:00 p.m. ETCLEVELAND--(BUSINESS WIRE)--$ATHX #investorconference--Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a panel discussion with leading neurology experts...

Related Keywords

Japan ,United States ,Elizabeth Blanton Wareing ,S Thomas Carmichael ,Sean Savitz ,Robertw Mays ,Peter Vozzo ,Frances Stark ,Karen Hunady ,David Schull ,Ivor Macleod ,David Chiu ,Lawrence Wechsler ,Linkedin ,Department Of Neurology ,Twitter ,Russo Partners ,Perelman School Of Medicine ,Weill Cornell Medical College ,Nasdaq ,Harvard University ,Facebook ,Eddy Scurlock Stroke Center ,Uthealth Houston Institute For Stroke Cerebrovascular Diseases ,David Geffen School Of Medicine ,Corporate Communications ,University Of Pennsylvania ,Panel Event ,Athersys Inc ,Frances Stark Chair ,David Geffen School ,Elizabeth Blanton Wareing Chair ,Houston Methodist Hospital ,Houston Institute ,Cerebrovascular Diseases ,Pennsylvania Hospital ,Perelman School ,Vice President ,Regenerative Medicine ,Private Securities Litigation Reform Act ,Investor Relations ,